Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Altimmune
ALT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$7.79
0.22
2.91%
At Close: -
$7.72
-0.07
-0.90%
After Hours: 7:37 PM EDT
15 minutes delayed
Get Report
Comment
Altimmune (ALT) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Altimmune (NASDAQ:ALT) Stock
Altimmune Stock (NASDAQ: ALT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, September 10, 2024
Altimmune shares are trading higher after the...
Benzinga Newsdesk
Altimmune Corrects Previous Release; Says Red...
Benzinga Newsdesk
Altimmune Presents Data From Its Phase 2, MRI...
Benzinga Newsdesk
Thursday, August 22, 2024
Decoding 4 Analyst Evaluations For Altimmune
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Altimmu...
Benzinga Newsdesk
Monday, August 12, 2024
B. Riley Securities Reiterates Buy on Altimmu...
Benzinga Newsdesk
Thursday, August 08, 2024
Altimmune shares are trading higher. The comp...
Benzinga Newsdesk
CORRECTION: Altimmune Q2 2024 GAAP EPS $(0.35...
Benzinga Newsdesk
Thursday, June 27, 2024
Shares of Altimmune are trading higher after ...
Benzinga Newsdesk
Watching Altimmune; Traders Circulate New Yor...
Benzinga Newsdesk
Wednesday, June 26, 2024
Why Are Altimmune Shares Trading Lower Wednesday?
Vaishali Prayag
Altimmune shares are trading lower following ...
Benzinga Newsdesk
Altimmune Announces Passing Of Chief Financia...
Benzinga Newsdesk
Tuesday, June 25, 2024
B. Riley Securities Reiterates Buy on Altimmu...
Benzinga Newsdesk
Monday, June 24, 2024
Altimmune Stock Is Rising Monday: What's Driving The Action?
Adam Eckert
Market-Moving News for June 24th
Benzinga Newsdesk
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Altimmune shares are trading higher after the...
Benzinga Newsdesk
Sunday, June 23, 2024
Altimmune Presents Data Sunday From Phase 2 M...
Benzinga Newsdesk
Friday, June 21, 2024
Forecasting The Future: 5 Analyst Projections For Altimmune
Benzinga Insights
Piper Sandler Maintains Overweight on Altimmu...
Benzinga Newsdesk
Wednesday, June 05, 2024
Altimmune Presents New Data on Pemvidutide's ...
Benzinga Newsdesk
Monday, June 03, 2024
How Is The Market Feeling About Altimmune?
Benzinga Insights
Friday, May 17, 2024
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
Zacks
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on Altimmu...
Benzinga Newsdesk
Friday, May 10, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Thursday, May 09, 2024
Altimmune Q1 2024 GAAP EPS $(0.34) Beats $(0....
Benzinga Newsdesk
Tuesday, May 07, 2024
Jim Cramer Calls Nutanix 'The Perfect Enterprise Software Company For The Moment'
Avi Kapoor
Tuesday, April 30, 2024
Peering Into Altimmune's Recent Short Interest
Benzinga Insights
Monday, April 29, 2024
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Deutsche Bank, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Altimmune shares are trading lower after Gugg...
Benzinga Newsdesk
Guggenheim Downgrades Altimmune to Neutral
Benzinga Newsdesk
Monday, April 08, 2024
How Is The Market Feeling About Altimmune?
Benzinga Insights
Wednesday, April 03, 2024
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
Benzinga Insights
Monday, April 01, 2024
HC Wainwright & Co. Maintains Buy on Altimmun...
Benzinga Newsdesk
Thursday, March 28, 2024
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
B. Riley Securities Reiterates Buy on Altimmu...
Benzinga Newsdesk
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Wednesday, March 27, 2024
Why Is Obesity Drug Developer Altimmune Stock Trading Lower On Wednesday?
Vandana Singh
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Altimmune shares are trading lower after the ...
Benzinga Newsdesk
Altimmune Q4 GAAP EPS $(0.54) Misses $(0.43) ...
Benzinga Newsdesk
Altimmune Announces Lean Mass Preservation Da...
Benzinga Newsdesk
Earnings Scheduled For March 27, 2024
Benzinga Insights
Tuesday, March 26, 2024
Altimmune's Earnings Outlook
Benzinga Insights
Friday, March 22, 2024
(ALT) - Analyzing Altimmune's Short Interest
Benzinga Insights
Tuesday, March 19, 2024
Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On'
Avi Kapoor
Monday, March 18, 2024
Here's How Much $100 Invested In Altimmune 5 Years Ago Would Be Worth Today
Benzinga Insights
Wednesday, February 28, 2024
Here's How Much $100 Invested In Altimmune 5 Years Ago Would Be Worth Today
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch